Implementing Risk-Based Monitoring – What Does ICH E6 Rev2 Mean for Me and My Company?

Recorded on March 14, 2017

For this webinar, CluePoints is teamed up with Paragon Solutions, to arm you with all you need to know about the ICH E6 Rev2 and what it’s means for you and your company.

Secrets of Successful RBM Revealed 

Webinar recorded on November 8, 2016

For this webinar, CluePoints is teaming up with Paragon Solutions, to arm you with all the information you need to plan, document, implement, and evolve a bullet-proof Risk-Based Monitoring strategy.

Statistical Methods to Detect Fraud and Errors in Clinical Data

Webinar recorded on September 19, 2016

In this recording, CluePoints Founder, Marc Buyse, discusses identifying data quality issues in submission data using statistical methods.

Removing the Risk in Risk-Based Monitoring – What We’ve learnt in the Past Four Years from the Practical Implementation of RBM

Webinar recorded on September 12, 2016

This recording details best practices for onboarding RBM that have been gained through implementation involving smaller and larger BioPharma sponsors and CROs.

The Complete Integrated Risk-Based Monitoring (RBM) Solution: Harnessing the Power of Multiple Technology Systems to Drive RBM and Overall Data Quality Oversight
January 21, 2016 

Join CluePoints and Oracle Health Sciences, to learn from two market leaders about an optimal way to get actionable results from the comprehensive analysis of clinical and operational data.

De-risking It All – A Systematic and Proven Approach to RBM and Data Quality Oversight

Recorded on April 29, 2015

In this webinar, learn from industry experts how a unique combination of data analytics and Electronic Data Capture is being harnessed by large, medium and smaller pharma to de-risk clinical studies and drive RBM. This partnership approach will ultimately allow an automated and unsupervised approach to ensure that no stone is left unturned in assessing and improving data quality and, hence, improving patient safety. The webinar also explores the value of an integrated approach to comprehensive clinical and operational data analysis.

Risk-Based Monitoring – What We’ve Learned in a Year, a Large Pharma Perspective from Sanofi

Webinar recorded on May 28, 2014

In this webinar recording, learn about how Sanofi-Aventis harnessed Central Statistical monitoring techniques to improve data quality and oversight. This session showcases the impact that Sanofi has had on enhancing its technology-driven approach.

Risk-Based Monitoring and Central Statistical Monitoring – A Regulatory Perspective on What is Expected from an Independent and objective Assessment of Clinical Data

Webinar recorded on March 25, 2014 

This webinar recording provides a regulatory perspective on what is expected from an independent and objective assessment of clinical data. Discussion points include what the FDA and EMA are encouraging sponsors to look at as part of their assessment of data quality, the types of data analysis required to de-risk studies and more.

Risk-Based Monitoring Improves Data Quality – It’s a Fact!

Webinar recorded on September 25, 2015 

In this webinar recording, Cubist Pharmaceuticals and CluePoints explore how sponsors are harnessing the power of Central Statistical Monitoring (CSM) to improve data quality and de-risk their studies. Discussion points include Risk-Based Monitoring, how to harness Central Statistical Monitoring in trials and more.

Removing the Risk in Risk-Based Monitoring – A Practical and Proven Approach to Implementing Central Statistical Monitoring

Webinar recorded on June 10, 2013

This webinar recording provides an in-depth examination of Central Statistical Monitoring (CSM) with an emphasis on statistical principles underlying Central Statistical Monitoring, On-Site Monitoring V.S CSM and more.